VYNE announces 1-for-50 reverse stock split and $17.3M special dividend for Yarrow merger

VYNE Therapeutics Inc.

Reverse stock split at 1-for-50 reduces outstanding shares from ~33.4M to ~0.7M.
Aggregate special cash dividend of $17.3M ($0.40242/share) payable July 23 to holders of record July 22.
Merger with Yarrow Bioscience expected to close July 24; combined company to trade as YARW on Nasdaq on July 27.
Post-merger combined company shares: ~2.7M basic, ~33.6M fully diluted.
Stockholders approved reverse split and increase in authorized shares from 150M to 300M at July 16 special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.